Cargando…

Antiviral activities of ISG20 in positive-strand RNA virus infections

ISG20 is an interferon-inducible 3′–5′ exonuclease that inhibits replication of several human and animal RNA viruses. However, the specificities of ISG20's antiviral action remain poorly defined. Here we determine the impact of ectopic expression of ISG20 on replication of several positive-stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhi, Wang, Nan, Woodson, Sara E., Dong, Qingming, Wang, Jie, Liang, Yuqiong, Rijnbrand, Rene, Wei, Lai, Nichols, Joan E., Guo, Ju-Tao, Holbrook, Michael R., Lemon, Stanley M., Li, Kui
Formato: Texto
Lenguaje:English
Publicado: Elsevier Inc. 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018280/
https://www.ncbi.nlm.nih.gov/pubmed/21036379
http://dx.doi.org/10.1016/j.virol.2010.10.008
_version_ 1782196044866519040
author Zhou, Zhi
Wang, Nan
Woodson, Sara E.
Dong, Qingming
Wang, Jie
Liang, Yuqiong
Rijnbrand, Rene
Wei, Lai
Nichols, Joan E.
Guo, Ju-Tao
Holbrook, Michael R.
Lemon, Stanley M.
Li, Kui
author_facet Zhou, Zhi
Wang, Nan
Woodson, Sara E.
Dong, Qingming
Wang, Jie
Liang, Yuqiong
Rijnbrand, Rene
Wei, Lai
Nichols, Joan E.
Guo, Ju-Tao
Holbrook, Michael R.
Lemon, Stanley M.
Li, Kui
author_sort Zhou, Zhi
collection PubMed
description ISG20 is an interferon-inducible 3′–5′ exonuclease that inhibits replication of several human and animal RNA viruses. However, the specificities of ISG20's antiviral action remain poorly defined. Here we determine the impact of ectopic expression of ISG20 on replication of several positive-strand RNA viruses from distinct viral families. ISG20 inhibited infections by cell culture-derived hepatitis C virus (HCV) and a pestivirus, bovine viral diarrhea virus and a picornavirus, hepatitis A virus. Moreover, ISG20 demonstrated cell-type specific antiviral activity against yellow fever virus, a classical flavivirus. Overexpression of ISG20, however, did not inhibit propagation of severe acute respiratory syndrome coronavirus, a highly-pathogenic human coronavirus in Huh7.5 cells. The antiviral effects of ISG20 were all dependent on its exonuclease activity. The closely related cellular exonucleases, ISG20L1 and ISG20L2, did not inhibit HCV replication. Together, these data may help better understand the antiviral specificity and action of ISG20.
format Text
id pubmed-3018280
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-30182802012-01-20 Antiviral activities of ISG20 in positive-strand RNA virus infections Zhou, Zhi Wang, Nan Woodson, Sara E. Dong, Qingming Wang, Jie Liang, Yuqiong Rijnbrand, Rene Wei, Lai Nichols, Joan E. Guo, Ju-Tao Holbrook, Michael R. Lemon, Stanley M. Li, Kui Virology Article ISG20 is an interferon-inducible 3′–5′ exonuclease that inhibits replication of several human and animal RNA viruses. However, the specificities of ISG20's antiviral action remain poorly defined. Here we determine the impact of ectopic expression of ISG20 on replication of several positive-strand RNA viruses from distinct viral families. ISG20 inhibited infections by cell culture-derived hepatitis C virus (HCV) and a pestivirus, bovine viral diarrhea virus and a picornavirus, hepatitis A virus. Moreover, ISG20 demonstrated cell-type specific antiviral activity against yellow fever virus, a classical flavivirus. Overexpression of ISG20, however, did not inhibit propagation of severe acute respiratory syndrome coronavirus, a highly-pathogenic human coronavirus in Huh7.5 cells. The antiviral effects of ISG20 were all dependent on its exonuclease activity. The closely related cellular exonucleases, ISG20L1 and ISG20L2, did not inhibit HCV replication. Together, these data may help better understand the antiviral specificity and action of ISG20. Elsevier Inc. 2011-01-20 2010-10-30 /pmc/articles/PMC3018280/ /pubmed/21036379 http://dx.doi.org/10.1016/j.virol.2010.10.008 Text en Copyright © 2010 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zhou, Zhi
Wang, Nan
Woodson, Sara E.
Dong, Qingming
Wang, Jie
Liang, Yuqiong
Rijnbrand, Rene
Wei, Lai
Nichols, Joan E.
Guo, Ju-Tao
Holbrook, Michael R.
Lemon, Stanley M.
Li, Kui
Antiviral activities of ISG20 in positive-strand RNA virus infections
title Antiviral activities of ISG20 in positive-strand RNA virus infections
title_full Antiviral activities of ISG20 in positive-strand RNA virus infections
title_fullStr Antiviral activities of ISG20 in positive-strand RNA virus infections
title_full_unstemmed Antiviral activities of ISG20 in positive-strand RNA virus infections
title_short Antiviral activities of ISG20 in positive-strand RNA virus infections
title_sort antiviral activities of isg20 in positive-strand rna virus infections
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018280/
https://www.ncbi.nlm.nih.gov/pubmed/21036379
http://dx.doi.org/10.1016/j.virol.2010.10.008
work_keys_str_mv AT zhouzhi antiviralactivitiesofisg20inpositivestrandrnavirusinfections
AT wangnan antiviralactivitiesofisg20inpositivestrandrnavirusinfections
AT woodsonsarae antiviralactivitiesofisg20inpositivestrandrnavirusinfections
AT dongqingming antiviralactivitiesofisg20inpositivestrandrnavirusinfections
AT wangjie antiviralactivitiesofisg20inpositivestrandrnavirusinfections
AT liangyuqiong antiviralactivitiesofisg20inpositivestrandrnavirusinfections
AT rijnbrandrene antiviralactivitiesofisg20inpositivestrandrnavirusinfections
AT weilai antiviralactivitiesofisg20inpositivestrandrnavirusinfections
AT nicholsjoane antiviralactivitiesofisg20inpositivestrandrnavirusinfections
AT guojutao antiviralactivitiesofisg20inpositivestrandrnavirusinfections
AT holbrookmichaelr antiviralactivitiesofisg20inpositivestrandrnavirusinfections
AT lemonstanleym antiviralactivitiesofisg20inpositivestrandrnavirusinfections
AT likui antiviralactivitiesofisg20inpositivestrandrnavirusinfections